Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02334722 : 1 Week Versus 6 Weeks of Levetiracetam in Surgical Brain Tumor Patients
PhasePhase 4
AgesMin: 18 Years Max: N/A
Inclusion Criteria:

- Adult (>18 years of age and older) patients who have or will have undergone surgical
resection or biopsy of a supratentorial brain tumor and are able to consent for

- Able to be randomized prior to or up to 48 hours after surgery.

Exclusion Criteria:

- No known history of seizure activity.

- Pregnant or breastfeeding.

- Renal dysfunction (CrCl < 30ml/min).

- Beck's Depression Inventory (BDI) =14

- Allergy to levetiracetam.
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557